Highlights
ACS Central Science: These Graphene Experts Are Trying to Close the Reproducibility Gap in Two-Dimensional Materials Research
14 May 2026Too much work on graphene and related materials cannot be repeated — a problem that wastes time and holds back commercialization. New rules could help solve it.
C&EN Talented 12: Aisulu Aitbekova
13 May 2026Combining light and heat to produce sustainable chemicals.
C&EN Talented 12: Martina Benešová-Schäfer
13 May 2026Building targeting systems for radioactive cancer treatments.
C&EN: Silicon insertion methods join skeletal-editing toolbox
06 May 2026Two teams take different approaches to squeeze silicon atoms into molecular scaffolds.
ACS Central Science: Pharm to Table Podcast Duo Bridges the Academia–Industry Divide
29 April 2026The Merck colleagues and cohosts advocate closer collaboration between academic and industry chemists.
TESTIMONIALS
“As an editor and reporter, Mark Peplow is fast, accurate, and versatile. He covers science policy and pure research with equal passion, and his writing combines a scientist’s precision with a journalist’s verve.” Tim Appenzeller
Former Chief Magazine Editor at Nature, now News Editor at Science
"Mark guided me through some of the most challenging stories I've written. These are pieces I might not have attempted were it not for his steady editorial hand." Linda Nordling
Freelance Journalist, South Africa
“Working with Mark is never anything other than a pleasure. He is the kind of editor that writers hope for: able to identify what needs fixing and what doesn’t, bringing to bear a wealth of knowledge, always clear, prompt and easy to talk with. Much of that comes from being a splendid writer himself.”
Philip Ball
Freelance Science Writer
Author Archives: Mark Peplow
Nature Biotechnology: Citizen science lures gamers into Sweden’s Human Protein Atlas
EVE Online combines space exploration, political intrigue, and now, an opportunity to spot proteins inside cells.
Posted in Highlights
Comments Off on Nature Biotechnology: Citizen science lures gamers into Sweden’s Human Protein Atlas
Nature: UK graphene inquiry reveals commercial struggles
Concerns about the University of Manchester’s National Graphene Institute reflect a broader decline in industrial research and development.
Posted in Highlights
Comments Off on Nature: UK graphene inquiry reveals commercial struggles
Chemistry World: Shadow of Chernobyl
Taking the long view on the cost of nuclear power.
Posted in Highlights
Comments Off on Chemistry World: Shadow of Chernobyl
The BMJ: The 100 000 Genomes Project
Part research project, part commercial stimulus, this enormous sequencing programme could usher genomic medicine into mainstream use.
Posted in Highlights
Comments Off on The BMJ: The 100 000 Genomes Project
Chemistry World: Family friendly science
The perception that young scientists need to sacrifice family life for a career in research must change.
Posted in Highlights
Comments Off on Chemistry World: Family friendly science
Chemical & Engineering News: Stale beer? There’s an app for that
Brewers could use a smartphone to read a simple colorimetric test for beer freshness.
Posted in Highlights
Comments Off on Chemical & Engineering News: Stale beer? There’s an app for that
Spectrum: My Subterranean Tour of London’s Crossrail
It’s a damp, freezing cold day in January, and I’m at the bottom of a massive hole in the ground …
Posted in Highlights
Comments Off on Spectrum: My Subterranean Tour of London’s Crossrail
Spectrum: The Digital Underground
London’s Crossrail Is a $21 Billion Test of Virtual Modeling.
Posted in Highlights
Comments Off on Spectrum: The Digital Underground
Crusading editor aims to shake things up in science
A profile of the BMJ’s editor, Fiona Godlee, for STAT magazine.
Posted in Profile
Comments Off on Crusading editor aims to shake things up in science
Malaria drug meets market resistance
Exclusive news article for Nature about artemisinin.
Posted in News reporting
Comments Off on Malaria drug meets market resistance
